SCHEMBL8296273

SCHEMBL8296273

COC(=O)/C=C/c1ccc(N)c(Cl)c1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.46
KDM4E B2RXH2 5/20 0.46
MAPT P10636 4/20 0.46
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
HPGD P15428 1/20 0.46
ALOX15 P16050 1/20 0.46
CYP2C19 P33261 1/20 0.46
HSD17B10 Q99714 1/20 0.46
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
TYR P14679 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
TTR P02766 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4283165 0.82 ALDH1A1 (0.59) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL4283168 0.82 ALDH1A1 (0.59) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL6499057 0.81 ALDH1A1 (0.46) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL6499060 0.81 ALDH1A1 (0.46) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL3167924 0.79 MAPT (0.49) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL6567144 0.79 ITGB2 (0.49) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL3179934 0.79 ABL1 (0.51) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL3167942 0.79 MAPT (0.49) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL3179944 0.79 ABL1 (0.51) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL6240384 0.78 ALDH1A1 (0.44) ALDH1A1KDM4EMAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed